There is no diagnostic testing that can identify<unk> . A diagnosis is made clinically based upon identification of characteristic symptoms in an affected infant in conjunction with a history of phenytoin exposure during gestation. It is important to note that the majority of infants born to women who take phenytoin during pregnancy will not develop<unk> .
Fetal hydantoin syndrome
Fetal trimethadione syndrome
Uremic fetor
Fetal warfarin syndrome
Neonatal encephalopathy
Neonatal sepsis
Neonatal hypocalcemia
Neonatal meningitis